Abstract
Glucuronidation of 5-DFCR, a metabolite of capecitabine, was confirmed in experimental models from rats whereas 5-DFCR glucuronide was detected neither in bile or liver from mice nor in livermicrosomes from human. Metabolic interactions at the level of the glucuronidation pathway between CAP and other drugs are unlikely in patients.
Keywords: Capecitabine, glucuronide, human, rat, mice, cytidine deaminase
Drug Metabolism Letters
Title: A Glucuronidation Pathway of Capecitabine Occurs in Rats but Not in Mice and Humans
Volume: 1 Issue: 2
Author(s): F. Desmoulin, C. Claparols, D. Bon, G. Larrieu, R. Martino and M. Malet-Martino
Affiliation:
Keywords: Capecitabine, glucuronide, human, rat, mice, cytidine deaminase
Abstract: Glucuronidation of 5-DFCR, a metabolite of capecitabine, was confirmed in experimental models from rats whereas 5-DFCR glucuronide was detected neither in bile or liver from mice nor in livermicrosomes from human. Metabolic interactions at the level of the glucuronidation pathway between CAP and other drugs are unlikely in patients.
Export Options
About this article
Cite this article as:
Desmoulin F., Claparols C., Bon D., Larrieu G., Martino R. and Malet-Martino M., A Glucuronidation Pathway of Capecitabine Occurs in Rats but Not in Mice and Humans, Drug Metabolism Letters 2007; 1 (2) . https://dx.doi.org/10.2174/187231207780363615
DOI https://dx.doi.org/10.2174/187231207780363615 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Related Articles
-
Antioxidant Activities and Total Phenolics Contents from Extracts of Terminalia catappa, Carrisa carandas, and Opuntia ficus indica Fruits
Recent Innovations in Chemical Engineering Antimetastatic Potential of Quercetin Analogues with Improved Pharmacokinetic Profile: A Pharmacoinformatic Preliminary Study
Anti-Cancer Agents in Medicinal Chemistry Screening for Marine Natural Products with Potential as Chemotherapeutics for Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Analytical Quality by Design Approach for Development of a Validated Bioanalytical UPLC Method of Docetaxel Trihydrate
Current Pharmaceutical Analysis Proteomics as Applied to Inherited Metabolic Diseases
Current Proteomics Mass Spectrometry Based Strategies in Quantitative Proteomics
Current Analytical Chemistry Nano-Based Anti-Tubercular Drug Delivery and Therapeutic Interventions in Tuberculosis
Current Drug Targets Efficacy and Safety of Nonopioid Analgesics in Perioperative Pain Control
Current Drug Safety Recent Advances in Efficacy of using Doxorubicin Gold Nanoparticles for Chemo-, Radio-, Photothermal, and Photodynamic Therapy
Current Drug Delivery A Guide to Template Based Structure Prediction
Current Protein & Peptide Science Recent Advances in QSAR and Their Applications in Predicting the Activities of Chemical Molecules, Peptides and Proteins for Drug Design
Current Protein & Peptide Science In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N’-di-2-propanoic Acid
Anti-Cancer Agents in Medicinal Chemistry Effect of Thawing Conditions on Polyphenol Content and Antioxidant Activity of Frozen Haskap Berries (<i>Lonicera caerulea L.</i>)
Current Nutrition & Food Science Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Combining In Silico Protein Stability Calculations with Structure-Function Relationships to Explore the Effect of Polymorphic Variation on Cytochrome P450 Drug Metabolism
Current Drug Metabolism Translational Research and Standardization in Optical Imaging
Current Molecular Imaging (Discontinued) Insights on Antimicrobial Resistance, Biofilms and the Use of Phytochemicals as New Antimicrobial Agents
Current Medicinal Chemistry Designing Prodrugs Based on Special Residues of Human Serum Albumin
Current Topics in Medicinal Chemistry Proteomic Profiling of a Biomimetic Drug Delivery Platform
Current Drug Targets Meet Our Editor
Current Metabolomics